No Stock Yet
Wuxi Biologics was re-selected into the FTSE Social responsibility Index.
Shanghai, Aug. 17 / PRNewswire-FirstCall-Asianet /-- Wuxi Biologics (WuXi Biologics, 2269.HK), a leading global contract research, development and production (CRDMO) company, has been re-listed in the FTSE Social responsibility Index (FTSE4Good Index), becoming the only healthcare company in the top 10 emerging market stocks in the index. The FTSE Social responsibility Index series, provided by FTSE Russell, the information services arm of the London Stock Exchange Group (LSEG), aims to screen out
Bank of China Securities: dual-target drug use has become the future, it is recommended to pay attention to the company that already has double-resistance technology platform.
According to a research report issued by Bank of China Securities, bispecific antibodies can specifically combine two antigens or different epitopes of one antigen at the same time, and through their mode of action, they can achieve functions that monospecific antibodies cannot achieve, and are expected to solve potential problems such as single-target drug resistance and lack of safety. The overall research and development is too early, the international pharmaceutical giant has entered the bureau, and the domestic market has followed up quickly. It is recommended to pay attention to the companies that already have double-antibody technology platforms, such as Wuxi Biologics, Genscript Biotech Corporation, Kangfang Biological-B, Corning Jerry Pharmaceutical-B, and Platinum Pharmaceutical-B, Sino Biopharmaceutical.
WuXi Biologics Again Selected as Constituent of FTSE4Good Index Series
SHANGHAI, Aug. 16, 2022 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global leading Contract Research, Development and Manufacturing Organization (CRDMO), announced today that it has onc
Look ahead for a week | Tencent, XIAOMI and other financial reports hit! The minutes of the Fed's July monetary policy meeting will be released. What is the impact on the prospect of raising interest rates?
Investors can also follow the heavyweight economic data, the monthly rate of US retail sales, the number of US jobless claims, and the results of a series of reviews of the Hang Seng Index in the second quarter.
North Water trend | North Water transaction net purchase of 956 million of domestic capital to increase the holding of science and technology stocks, telecom operator Tianqi Lithium Industry (09696) received additional positions.
Zhitong Financial APP learned that on August 11, the Hong Kong stock market saw a net purchase of 956 million in North Water, with a net purchase of HK $82 million in Hong Kong Stock Connect (Shanghai) and HK $874 million in Hong Kong Stock Connect (Shenzhen). The stocks that Beishuijing bought the most were Meituan-W (03690), Sunny Optical (02382) and China Telecom Corporation (00728). The stocks sold most by Beishuijing are Hong Kong Stock Exchange (00388), China Overseas Land & Investment (00688) and Semiconductor Manufacturing International Corporation (00981). Hong Kong Stock Connect (Shanghai) Top Ten active Trading stocks Hong Kong Stock Connect (Shenzhen) Ten active Trading stocks Beishui Capital increase position
Hong Kong stocks closed (8.11) | the Hang Seng Index rose 2.4%, the main board slightly shrank, leading the way in electronics, Internet, finance and other sectors.
Zhitong Financial APP learned that the three major stock indexes rebounded collectively, fully recovering yesterday's lost ground, and trading volume on the main board shrank. Early trading, the index opened sharply higher after a consolidation, the second half of the index pulled up again. In the afternoon, the stock index continued to recover and hit a session high at the close, and the Hang Seng Index returned above the 20,000 mark. As of the close, the Hang Seng Index was up 2.40% or 471.59 points at 20082.43, with a full-day turnover of HK $82.714 billion; the China Enterprises Index was up 2.70% at 6823.39; and the Hang Seng Technology Index was up 3.67% at 4326.85. The influence of permanent Index position: BABA-SW
Hong Kong pharmaceutical stocks continue to rise.
Hong Kong stocks CXO concept stocks rose, Wuxi Apptec rose more than 5%, Zhaoyan new drug rose nearly 5%, Tigermed, Genscript Biotech Corporation rose more than 4%, Wuxi Biologics, Kellein rose nearly 4%.
Afternoon comment on Hong Kong stocks: the Hang Seng Index closed down 2.07% in early trading. The Hang Seng Technology Index fell 3.11%.
Southward Capital sold a net of 189 million yuan today.
No Stock Yet